Catheter Precision's stock, traded as VTAK, has experienced a sudden increase. The surge may be related to the company winning patents for heart rhythm and heart failure technology, as well as potential growth from other business developments. The exact reasons for the stock's jump are not entirely clear, but it has drawn attention from traders and resulted in a significant increase in the stock's value.